Viewing Study NCT02982005


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-02-25 @ 7:26 PM
Study NCT ID: NCT02982005
Status: COMPLETED
Last Update Posted: 2024-04-29
First Post: 2016-12-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea
Sponsor: Kyowa Kirin Korea Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Moderate to Severe Plaque Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KHK4827 (brodalumab) View